Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1963 1
1964 3
1965 1
1970 1
1971 2
1972 1
1983 1
1988 1
1989 3
1990 3
1991 3
1992 3
1993 6
1994 1
1995 6
1996 2
1997 4
1998 3
1999 6
2000 3
2001 2
2002 3
2003 3
2004 9
2005 7
2006 4
2007 4
2008 5
2009 3
2010 4
2011 3
2012 3
2013 4
2014 5
2015 5
2016 6
2017 7
2018 6
2019 9
2020 16
2021 15
2022 13
2023 10
2024 11
2025 15
2026 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

216 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean manzelli a[au] (52 results)?
Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH).
Sciacqua LV, Vanzulli A, Di Meo R, Pellegrino G, Lavorato R, Vitale G, Carrafiello G. Sciacqua LV, et al. Among authors: vanzulli a. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231155000. doi: 10.1177/15330338231155000. Technol Cancer Res Treat. 2023. PMID: 36794408 Free PMC article.
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.
Sartore-Bianchi A, Trusolino L, Martino C, Bencardino K, Lonardi S, Bergamo F, Zagonel V, Leone F, Depetris I, Martinelli E, Troiani T, Ciardiello F, Racca P, Bertotti A, Siravegna G, Torri V, Amatu A, Ghezzi S, Marrapese G, Palmeri L, Valtorta E, Cassingena A, Lauricella C, Vanzulli A, Regge D, Veronese S, Comoglio PM, Bardelli A, Marsoni S, Siena S. Sartore-Bianchi A, et al. Among authors: vanzulli a. Lancet Oncol. 2016 Jun;17(6):738-746. doi: 10.1016/S1470-2045(16)00150-9. Epub 2016 Apr 20. Lancet Oncol. 2016. PMID: 27108243 Free article. Clinical Trial.
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial.
Sartore-Bianchi A, Pietrantonio F, Lonardi S, Mussolin B, Rua F, Crisafulli G, Bartolini A, Fenocchio E, Amatu A, Manca P, Bergamo F, Tosi F, Mauri G, Ambrosini M, Daniel F, Torri V, Vanzulli A, Regge D, Cappello G, Marchiò C, Berrino E, Sapino A, Marsoni S, Siena S, Bardelli A. Sartore-Bianchi A, et al. Among authors: vanzulli a. Nat Med. 2022 Aug;28(8):1612-1618. doi: 10.1038/s41591-022-01886-0. Epub 2022 Aug 1. Nat Med. 2022. PMID: 35915157 Free PMC article. Clinical Trial.
Total neoadjuvant therapy followed by non-operative management or surgery in stage II-III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial.
Amatu A, Patelli G, Zampino MG, Bergamo F, Mosconi S, Tosi F, Ciardiello D, Lonardi S, Negrini G, Sibio D, Gerardi MA, Galuppo S, Filippone FR, Carnevali P, Borin S, Pilati P, Poiasina E, Bonazzina E, Gervaso L, Mammano E, Bracco F, Bergamaschi L, Spolverato G, Origi M, Romario UF, Mauri G, Fazio N, Forti E, De Roberto G, Cristofori C, Burti C, Asmundo L, Funicelli L, Ramondo G, Bonaffini PA, Mariano S, Lazzari L, Ghezzi S, Isella C, Cantarella D, Aquilano MC, Bottiglieri L, Bonoldi E, Mutignani M, Torri V, Medico E, Bardelli A, Marsoni S, Vanzulli A, Palazzi MF, Ferrari GC, Bencardino K, Sartore-Bianchi A, Siena S. Amatu A, et al. Among authors: vanzulli a. Lancet Oncol. 2025 Dec;26(12):1612-1625. doi: 10.1016/S1470-2045(25)00542-X. Lancet Oncol. 2025. PMID: 41308677 Clinical Trial.
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).
Drilon A, Siena S, Ou SI, Patel M, Ahn MJ, Lee J, Bauer TM, Farago AF, Wheler JJ, Liu SV, Doebele R, Giannetta L, Cerea G, Marrapese G, Schirru M, Amatu A, Bencardino K, Palmeri L, Sartore-Bianchi A, Vanzulli A, Cresta S, Damian S, Duca M, Ardini E, Li G, Christiansen J, Kowalski K, Johnson AD, Patel R, Luo D, Chow-Maneval E, Hornby Z, Multani PS, Shaw AT, De Braud FG. Drilon A, et al. Among authors: vanzulli a. Cancer Discov. 2017 Apr;7(4):400-409. doi: 10.1158/2159-8290.CD-16-1237. Epub 2017 Feb 9. Cancer Discov. 2017. PMID: 28183697 Free PMC article. Clinical Trial.
Radiomic features of primary retroperitoneal sarcomas: a prognostic study.
Pasquali S, Iadecola S, Vanzulli A, Infante G, Bologna M, Corino V, Greco G, Vigorito R, Morosi C, Beretta A, Percio S, Vallacchi V, Collini P, Sanfilippo R, Fabbroni C, Stacchiotti S, Fiore M, Huang P, Benelli M, Mainardi L, Miceli R, Gronchi A, Callegaro D. Pasquali S, et al. Among authors: vanzulli a. Eur J Cancer. 2024 Dec;213:115120. doi: 10.1016/j.ejca.2024.115120. Epub 2024 Nov 9. Eur J Cancer. 2024. PMID: 39541785 Free article.
Imaging of Urologic Trauma.
Asmundo L, Sgrazzutti C, Vanzulli A. Asmundo L, et al. Among authors: vanzulli a. Urol Clin North Am. 2025 Feb;52(1):61-73. doi: 10.1016/j.ucl.2024.07.008. Epub 2024 Oct 10. Urol Clin North Am. 2025. PMID: 39537305 Review.
Treatments and cancer: implications for radiologists.
Granata V, Fusco R, Setola SV, Borzacchiello A, Della Sala F, Rossi I, Ravo L, Albano D, Vanzulli A, Petrillo A, Izzo F. Granata V, et al. Among authors: vanzulli a. Front Immunol. 2025 Apr 16;16:1564909. doi: 10.3389/fimmu.2025.1564909. eCollection 2025. Front Immunol. 2025. PMID: 40308594 Free PMC article. Review.
216 results